文献速递前列腺癌肾癌与肾肿瘤

机器人辅助根治性前列腺切除术后急性肾损伤与急性肾脏病的发生率及预测因素

Incidence and Predictors of Acute Kidney Injury and Acute Kidney Disease After Robot-assisted Radical Prostatectomy in Prostate Cancer Patients.
PubMed 文献 · Eur Urol Oncol · 2025-07-11

这项在高容量三级中心开展的回顾性研究纳入3551例接受机器人辅助根治性前列腺切除术的前列腺癌患者,依据肌酐值定义急性肾损伤(术后7天内)和急性肾脏病(术后8-90天)。结果显示急性肾损伤发生率为3.7%,急性肾脏病发生率为18.5%,术前估算肾小球滤过率是急性肾脏病的强预测因素,基线eGFR低于80-85 ml/min/1.73 m2者风险更高。

要点

  • 机器人辅助根治性前列腺切除术后急性肾损伤发生率接近4%。
  • 约五分之一患者术后发生急性肾脏病。
  • 术前eGFR是急性肾脏病的强预测因素。

核心结论

  • 机器人辅助根治性前列腺切除术后急性肾损伤发生率接近4%,约五分之一患者面临急性肾脏病风险。
  • 术前估算肾小球滤过率是急性肾脏病的强预测因素。

研究设计与样本

  • 回顾性评估3551例在高容量三级中心连续接受机器人辅助根治性前列腺切除术的前列腺癌患者。
  • 使用电子健康记录依据肌酐值定义急性肾损伤(术后7天内)和急性肾脏病(术后8至90天)。
  • 采用LASSO回归筛选预测急性肾损伤和急性肾脏病的最终变量集。
  • 使用局部估计散点图平滑回归探索基线eGFR与模型预测的急性肾损伤或急性肾脏病概率之间的交互作用。

主要发现

  • 844例(23.8%)、2073例(58.4%)和634例(17.8%)患者分别具有低危、中危和高危前列腺癌。
  • 基线eGFR为86.8 ml/min/m2(四分位距:74.6-96.3)。
  • 131例(3.7%)和134例(18.5%)患者分别在机器人辅助根治性前列腺切除术后发生急性肾损伤和急性肾脏病。
  • 16例(2.2%)患者在术后发生慢性肾脏病≥3期。
  • 手术时年龄(p=0.042)和基线eGFR(p=0.002)分别是急性肾损伤和急性肾脏病的显著预测因素。

临床怎么用

  • 术前识别eGFR低于80-85 ml/min/1.73 m2的患者,可能有助于优化围手术期管理。
  • 对机器人辅助根治性前列腺切除术后患者应关注急性肾损伤和急性肾脏病的发生。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND OBJECTIVE: Acute kidney injury (AKI) and acute kidney disease (AKD) are neglected complications of robot-assisted radical prostatectomy (RARP) that may lead to chronic kidney disease (CKD). We investigated their incidence and predictors in prostate cancer (PCa) patients undergoing RARP. METHODS: Overall, 3551 consecutive patients who underwent RARP at a high-volume tertiary center were evaluated. Electronic health records were used to define AKI (within 7 d from surgery) and AKD (between 8 and 90 d after surgery) according to creatinine values. A Least Absolute Shrinkage and Selection Operator (LASSO) regression selected the final set of variables for predicting each outcome (AKI and AKD). A locally estimated scatterplot smoothing regression explored the interaction between baseline estimated glomerular filtration rate (eGFR) and the model-based probability of developing AKI or AKD. KEY FINDINGS AND LIMITATIONS: Overall, 844 (23.8%) vs. 2073 (58.4%) vs. 634 (17.8%) patients had low- vs. intermediate- vs. high-risk PCa. The baseline eGFR was 86.8 ml/min/m2 (interquartile range: 74.6-96.3). Overall, 131 (3.7%) and 134 (18.5%) patients experienced AKI and AKD after RARP, respectively, whereas 16 (2.2%) patients developed CKD stage ≥3 after surgery. Age at surgery (p = 0.042) and baseline eGFR (p = 0.002) were significant predictors of AKI and AKD, respectively. Patients with an eGFR of <80-85 ml/min/1.73 m2 at baseline were at a higher risk of developing AKI/AKD. CONCLUSIONS AND CLINICAL IMPLICATIONS: The incidence of AKI after RARP approaches 4%, and one out of five patients is at risk of AKD. Preoperative eGFR emerged as a strong predictor of AKD. Proper identification of patients at risk may lead to optimized intra- and postoperative management.

来源:Eur Urol Oncol,查看原文。版权归原作者所有。

引用

  1. Zaurito P, Calado A, Quarta L, et al. Incidence and Predictors of Acute Kidney Injury and Acute Kidney Disease After Robot-assisted Radical Prostatectomy in Prostate Cancer Patients. Eur Urol Oncol. 2025. PMID: 40645822. doi:10.1016/j.euo.2025.06.011

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。